Fluence has a long history of providing high-quality, evidence-based training for mental health professionals in psychedelic therapy. In 2024 we partnered with Lycos, the sponsor of MDMA-assisted therapy research trials, to offer an MDMA-Assisted Therapy Education Program. However, as the field awaits regulatory decisions, we have paused additional MDMA-Assisted Therapy education.
At this time, we are closely monitoring developments in the approval process and will update this page with any future education and training opportunities as they become available.
While Fluence is not currently offering a full MDMA-Assisted Therapy education program, we provide the following educational resources for clinicians who want to stay informed:
We encourage clinicians to engage with these resources to deepen their understanding of MDMA therapy and its potential future applications.
While MDMA-assisted therapy training is on hold, clinicians looking to expand their expertise in psychedelic therapy can explore the following options at Fluence:
These programs provide valuable knowledge and skills that are highly relevant for therapists interested in the evolving field of psychedelic-assisted therapy.
